Abstract
Introduction

61
The gut microbiota plays a crucial role in human physiology and host development (41), and 62 maintaining equilibrium between the commensal microbiota and the host immune system is 63 required for a healthy gut homeostasis.
64
There is increasing evidence for a contribution of the gut microbiome to the etiology of IBD (18). In 65 the past, genome-wide association studies have revealed multiple host gene loci in both UC and 66 CD, with alleles associated with functional aberrations of the intestinal immune system (18). Recent 67 studies based on novel DNA sequencing methods have revealed major differences in bacterial 68 taxonomic composition between IBD patients and healthy individuals (see Appendix Table 1 ). Still,
69
it remains unclear whether these observed alterations are the cause or result of inflammation.
70
Since most studies on the IBD microbiome to date have relied on 16S rRNA sequencing, the 71 functional impact of the reported dysbiosis is not well understood (23) , and reported associations 72 are largely limited to identifying more general taxa (ranging from bacterial phyla to genera) as 
Index (PCDAI) (14). In total, fecal samples from six Ulcerative Colitis (UC) patients and six
98
Crohn's Disease (CD) patients and from 12 controls were collected from August 2013 to July 2014.
99
Controls were healthy siblings of the IBD patients, sharing the same parents and living in the same 100 households, thereby sharing genetic background, environment and diet. In addition, study 101 participants completed a questionnaire about health/disease status, living conditions, and alimentary 102 habits. Children who had taken antibiotics during the last 2 months prior to sampling were excluded 103 from the study. For additional cohort characteristics see Table 1 . Since all study participants are 104 older than 8 years, and thus should have relatively stable microbiomes, we do not anticipate age 105 differences between patients and healthy siblings to have a strong impact on results.
106
The study design was approved by the ethics committee of the State Chamber of Physicians of Rhineland-Palatinate (Ethikkomission der Landesärztekammer Rheinland-Pfalz, reference number 108 837.292.13 (8977-F)).
109
Written informed consent was given by both parents and the study participants prior to sample 110 collection and medical assessment.
111
Assessment of lifetime antibiotic intake
112
Antibiotic intake of the study population was retrospectively recorded, starting from birth.
113
Therefore, all physicians/hospitals who have treated the study participants were contacted and asked 114 to transfer their antibiotic prescription data for each child. Out of 306 person years of total 115 participant lifetime to date, only 16 (5 %) could not be covered by this assessment. 
Data analysis
131
Data analysis was performed at the Structural and Computational Biology Unit, EMBL, Heidelberg.
132
Taxonomic profiling
133
Using the MOCAT pipeline (21), gene sequences were annotated to their bacterial taxonomy. Since 134 many gut bacteria are known to belong to species for which no genome yet exists in public 135 databases, two different alignment procedures were used. The first procedure was based on 136 metagenomic operational taxonomic units (mOTUs) (43) which also encompass uncharacterized 137 bacteria identified in metagenomic dataset. The second procedure used species clusters defined 138 from bacterial genomes for which publicly deposited genomes do exist (27). In this manner as 139 complete coverage of the taxonomic composition of the samples as possible was achieved.
140
Analysis of bacterial diversity, species richness and evenness
141
Based on the mOTU taxonomic composition, Shannon diversity index, species richness and 142 evenness were calculated using the vegan R package (http://cran.r-
143
project.org/web/packages/vegan/index.html), for details see Zeller et al. 2014 (49) .
144
Functional profiling
145
To gain insight into metabolic functions of the microbiome, the metagenomic catalogue was aligned 
148
Identifying virulence factors
149
For virulence factor profiling of the metagenome samples, reads were mapped to virulence factor 150 gene families via an annotated gene catalog as described in Kultima et al., 2016 (20 
170
(9)).
171
Statistical analysis
172
In subsequent analyses, all read/base counts were transformed into relative abundances (by division 173 by the total number of reads/bases sequenced per sample) as described previously by Zeller et al., 174 2014 (49).
175
In order to identify significant differences between sample categories for each metagenomic feature, 176 a nonparametric Kruskal-Wallis-test (KW) was performed whenever the UC-, CD-and control-177 group were compared. This was followed by pairwise Mann-Whitney-U-tests (MWU) as a post-hoc 178 procedure.
179
For data sets not normally distributed, the Wilcoxon signed-rank test was employed to compare sib 180 pairs directly. Correlation analyses were performed using Spearman rank's correlation coefficient
181
(SCC), in order to fit potentially non-normal data.
182
In cases of multiple testing p-value correction via the Benjamini-Hochberg false discovery rate community evenness (see Figure 1 ).
216
Differences in taxonomic abundances from former 16S rRNA analyses are validated by WGS
217
Considering those bacterial taxa previously noted as being altered in prevalence or abundance in 218 IBD (cf Appendix Table 1 ), many of these findings could be recaptured as significant in the present Table 1 ).
224
If we do not restrict analysis to validation of 16S results only, power is reduced due to the increased 225 number of tested hypotheses. However, 55% (17 out of 31) of the findings described above also
226
show associations with IBD approaching significance without such preselection and with 227 subsequently more stringent FDR correction (Supplementary Table 3 ). The previously described 228 associations constitute the majority of significant associations found in the unrestricted search,
229
suggesting most obvious associations already were reported at least once from 16S data. However,
230
another four taxa approached significance in the unrestricted test, which had not previously been Clostridium ramosum was significantly enriched in UC patients compared to the set of controls 237 (FDR <.001). abundance of E. coli. All of these genes, except hslT, were previously described and identified as 255 occurring in strains of E. coli (see Supplementary Table 2) . In all three groups cephalosporin was the most commonly prescribed antibiotic, followed by by IBD patients, and a tetracycline antibiotic was only taken once by one subject in the control 275 group.
238
Enrichment of pathobiont species and depletion of commensals
276
The resistome of IBD patients and their healthy siblings
277
In accordance with previous studies (9), tetracycline was the antibiotic for which the most Table 2 ).
342
The strong correlation of the abundance of virulence genes enriched in the UC microbiome with E.
343
coli abundance suggests that this species is a central driver of a functional shift towards virulence in 344 UC patients of the present cohort, underscoring its potential role as an IBD partial cause.
345
Survival strategies of bacteria -relating virulence capacity to pathology
346
The virulence genes enriched in the UC microbiome included TonB, sitA, IroN, fepA and Fur. They antibiotics not only leads to shifts in taxonomic composition, but also induces the lateral transfer 365 and spread of antibiotic resistance genes in a microbial ecosystem (38) .
366
Notably, the quantification of antibiotic resistance genes in the microbiomes of the present cohort 367 revealed no significant difference in the relative abundance of these genes between IBD patients 368 and their healthy siblings, and similar retrospective assessments of antibiotic intake in both groups.
369
In other words, while it seems unlikely the IBD discordance within the sib pairs can be explained by family members living in close contact. In contrast, a significant shift in both IBD conditions 376 towards a higher abundance of species potentially carrying antibiotic resistance genes was revealed.
377
This measure could not be reliably predicted from individual antibiotics use history within the 378 present dataset, however.
379
Besides antibiotic treatment, intake of IBD medications has recently been lined out as a covariate of 380 microbiome variation in a large-scale study (7). Due to cohort size, we had not the power to detect 381 such effects, although they need to be assumed (Table 1) . in the same home already should be similar. 
